Effects of ketanserin on headache prophylaxis. A randomized, double-blind, placebo-controlled study

Machine translation Machine translation
Authors
Category Primary study
JournalGiornale di Neuropsicofarmacologia
Year 1991
Studied the clinical efficacy of ketanserin for the prophylactic treatment of headaches. Human Ss: 40 male and female Italian adults (mean age 46.2 yrs) (headaches). Drugs used: Ss were treated with ketanserin (20–40 mg/day) or placebo for 30 days. Clinical effectiveness was evaluated using the Migraine Index, a questionnaire on the frequency and intensity of migraine; and the presence of side effects was studied. Statistical tests were used.
Epistemonikos ID: 80b768e436f27212ed9357bc03cb1594f839e4f2
First added on: May 06, 2025
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: Italiano

If you prefer to see the machine translation we assume you accept our terms of use